Pulmonary Hypertension Registry - An Observational Project

Recruiting

• Conditions: Patients diagnosed with pulmonary hypertension

• Registration Number: CTRI/2012/03/002514
• Lead Sponsor: Medanta The Medicity

Brief Summary

Hypothesis - Pulmonary Hypertension(PH) is a grave disease that affects the functional quality of the patients with high morbidity and mortality. The advent of new drugs and better understanding of pathophysiology has resulted in better outcomes. It is likely that available treatment will change the natural course of disease and perhaps prolongs survival.

Purpose - The purpose of the PH Registry is to study the natural course of pulmonary hypertension and response to disease modifying drugs in subjects visiting the Medanta PH Clinic.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-21
• Last Update Posted: 2012-01-03

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Able to provide consent.
• Newly or previously diagnosed as having Pulmonary Hypertension.

Exclusion Criteria

Not meeting inclusion criteria.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality and morbidity due to Pulmonary Hypertension in Indian population	More than 2 years

Secondary Outcome Measures

Name	Time	Method
Time lag between onset of first symptom and initial diagnosis of pulmonary hypertension	More than 2 years

Trial Locations

Locations (1)

Medanta, The Medicity; 🇮🇳 Gurgaon, HARYANA, India

Medanta, The Medicity

🇮🇳Gurgaon, HARYANA, India

Dr Rahul Mehrotra

Principal investigator

9971698201

rahul.mehrotra@medanta.org